Among the acquired forms of FGF23-dependent hypophosphatemia, there is tumor-induced osteomalacia (TIO), a rare paraneoplastic condition characterized by bone demineralization and a loss of phosphate through the kidney. Here, FGF23 is linked to hypophosphatemia.